Gorusu, Madhavi, MD
Hartford HealthCare Medical Group

Madhavi Gorusu, MD

Medical Oncology

Location Information

  • Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut
    540 Litchfield Street 6th Floor
    Torrington, CT 06790

    860.496.6825

    Fax: 860.496.6882

About Madhavi Gorusu, MD

  • Gender
    Female
  • Language
    English
    Providing the best care to our patients and their companions requires communicating in a way everyone understands. Interpreter services are available 24 hours a day, 7 days a week, 365 days a year. All spoken languages are available, as well as American Sign Language (AS/L)
  • Specialties
    Accepting New Patients

    Medical Oncology, Hematology / Oncology

    Not Currently Accepting New Patients

    Internal Medicine

  • Areas of Expertise
    Breast Cancer, Lung Cancer, Lymphoma, Myelomas

Education

  • FellowshipJohn Dempsey Hospital
    University of Connecticut School of Medicine

    InternshipHuron Hospital (OH)

    Medical SchoolAndhra Medical College

  • Faculty Appointments

    University of Connecticut School of Medicine, Clinical Assistant Professor

  • Professional Organizations

    American Society of Clinical Oncology, Member
    American Society of Hematology, Member

Bio

Dr. Madhavi Gorusu is a hematologist/oncologist on the Hartford Hospital medical staff. She earned her medical degree from Andhra Medical College in India, and then completed a residency in internal medicine, partly through the Cleveland Clinic Health System and the University of Connecticut. She also completed a fellowship in hematology/oncology through UConn, and an elective in bone marrow transplant through the Yale University Blood Stem Cell Transplant Unit.

Board certified in internal medicine, medical oncology and hematology, she is a member of the American Society of Clinical Oncology and the American Society of Hematology. She is the founder of the Mahatma and Martin Luther King Junior Foundation in India, and has published extensively on such topics as T-cell prolymphocytic leukemia, drug interactions and rituximab-induced serum sickness masquerading as septic shock.

Media

Madhavi Gorusu, MD News

February 18, 2022

What the Memorial Sloan Kettering Cancer Alliance Means to Patients

The Hartford HealthCare Cancer Institute, as a cha [...]

Back to Top